Search

Therapeutic Drug Monitoring Market

Therapeutic Drug Monitoring Market Share & Analysis – Industry Overview

Base Year: 2022 Historical Data: 2019-21
  • Report ID: TBI-13397
  • Published Date: Apr, 2023
  • Pages: 237
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

Segment Analysis

Regional segmentation analysis

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the largest global therapeutic drug monitoring market, with a 43% market revenue share in 2022. The region is witnessing an increase in the incidence of autoimmune, cardiovascular, pulmonary and other chronic diseases, given the lifestyle changes in the population associated with high-stress levels, bad diet and no physical exercise. The well-established healthcare infrastructure enables patients to access precision treatment. Significant market players facilitate greater innovation in the therapeutic drug monitoring industry, which augments the market’s development. The increasing fiscal investment in research and development in the pharmaceutical and biotechnology industries will also bode well for the market. The wide coverage of healthcare services and favourable reimbursement policies also contribute to the region's growth in the global market.

North America Region Therapeutic Drug Monitoring Market Share in 2022 - 43%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Product type segment analysis

The product type segment is divided into equipment, consumables and others. The consumables segment dominated the market with a market share of around 54% in 2022. Consumables are products and equipment used more frequently with every test or group. They are used and thrown out afterwards. Syringes, beakers, funnels, test tubes, gloves, and liquids or dyes used for testing and analysis are some consumables used daily. These are used more frequently than long-lasting equipment. The rate of their consumption, given their significant rate of disposition, contributes to its dominance in the global therapeutic drug monitoring market.

Technology segment analysis

The technology is divided into spectrometry, electrophoresis, chromatography, proteomic technology, immunoassays and others. The immunoassays segment dominated the market with a market share of around 40% in 2022. An immunoassay is a testing method to establish the presence and concentration of drugs or certain molecules in a solution. Immunoassays are extensively used in drug development and discovery of drug analysis. It is also used in diagnostics and therapeutic drug monitoring. There are several types of immunoassays. Enzyme immunoassays (EIA), fluoro-immunoassays (FIA), radioimmunoassays (RIA), and chemiluminescent immunoassays (CLIA) are a few common examples. Given their high sensitivity and detection capabilities, immunoassays offer a quick, easy, and cost-effective drug monitoring method.

Drug class segment analysis

The drug class is divided into antibiotics, antiarrhythmic, bronchodilators, HIV/AIDS drugs, antineoplastics, immunosuppressive, antiepileptic and others. The antiepileptic segment dominated the market with a market share of around 39% in 2022. Antiepileptic drugs help in preventing seizures or convulsions. These drugs regulate the brain's electrical activity to control seizure activity. Antiepileptic drugs are used to treat seizure disorders like epilepsy. They specifically influence ion (sodium, potassium, calcium, and chloride) channels in the cell membrane. The ions are responsible for electrical activity, and controlling them helps reduce seizures. Topiramate, lamotrigine, carbamazepine, sodium valproate, and levetiracetam are antiepileptic drugs. They are used in treating migraine, and neuropathic pain, among other conditions.

End-user segment analysis

The end user is divided into hospitals, research and academic institutes, diagnostic labs and others. The hospital segment dominated the market with a market share of around 41% in 2022. Hospitals have the necessary infrastructure, equipment, consumables and professionals to perform therapeutic drug monitoring. Furthermore, most patients requiring therapeutic drug monitoring are admitted to hospitals, facilitating the segment's market dominance. The increasing fiscal expenditure on developing healthcare infrastructure will benefit the segment's growth.

Get Your Report Customized

  • Further segmentation of the market on the basis of type, application, end use, product, technology, method, process and any other segment depending on the market
  • Segmentation on the basis of any specific country or region
  • Any segment can be classified on the basis of application
  • Application segment can be further divided on the basis of companies
  • The companies profiled are not limited, we can incorporate additional companies of your choice
  • We can split the company market share on the basis of product, application and region
  • Report can be prepared for any specific country/region/segment
  • Customers can be added on the basis of regions and countries
Request for Customization

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis by Product Type
          4.3.2. Market Attractiveness Analysis by Technology
          4.3.3. Market Attractiveness Analysis by Drug Class
          4.3.4. Market Attractiveness Analysis by End User
          4.3.5. Market Attractiveness Analysis by Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. The increasing demand for organ transplants
    5.3. Restraints
          5.3.1. The high initial cost of investment
    5.4. Opportunities
          5.4.1. The increasing research and development
    5.5. Challenges
          5.5.1. The presence of simpler alternatives

6. Global Therapeutic Drug Monitoring Market Analysis and Forecast, By Product Type
    6.1. Segment Overview
    6.2. Equipment
    6.3. Consumables
    6.4. Others

7. Global Therapeutic Drug Monitoring Market Analysis and Forecast, By Technology
    7.1. Segment Overview
    7.2. Spectrometry
    7.3. Electrophoresis
    7.4. Chromatography
    7.5. Proteomic Technology
    7.6. Immunoassays
    7.7. Others

8. Global Therapeutic Drug Monitoring Market Analysis and Forecast, By Drug Class
    8.1. Segment Overview
    8.2. Antibiotics
    8.3. Antiarrhythmic
    8.4. Bronchodilators
    8.5. HIV/AIDS Drugs
    8.6. Antineoplastics
    8.7. Immunosuppressive
    8.8. Antiepileptic
    8.9. Others

9. Global Therapeutic Drug Monitoring Market Analysis and Forecast, By End User
    9.1. Segment Overview
    9.2. Hospitals
    9.3. Research and Academic Institutes
    9.4. Diagnostic Labs
    9.5. Others

10. Global Therapeutic Drug Monitoring Market Analysis and Forecast, By Regional Analysis
    10.1. Segment Overview
    10.2. North America
          10.2.1. U.S.
          10.2.2. Canada
          10.2.3. Mexico
    10.3. Europe
          10.3.1. Germany
          10.3.2. France
          10.3.3. U.K.
          10.3.4. Italy
          10.3.5. Spain
    10.4. Asia-Pacific
          10.4.1. Japan
          10.4.2. China
          10.4.3. India
    10.5. South America
          10.5.1. Brazil
    10.6. Middle East and Africa
          10.6.1. UAE
          10.6.2. South Africa

11. Global Therapeutic Drug Monitoring Market-Competitive Landscape
    11.1. Overview
    11.2. Market Share of Key Players in the Therapeutic Drug Monitoring Market
          11.2.1. Global Company Market Share
          11.2.2. North America Company Market Share
          11.2.3. Europe Company Market Share
          11.2.4. APAC Company Market Share
    11.3. Competitive Situations and Trends
          11.3.1. Product Launches and Developments
          11.3.2. Partnerships, Collaborations, and Agreements
          11.3.3. Mergers & Acquisitions
          11.3.4. Expansions

12. Company Profiles
    12.1. Abbott
          12.1.1. Business Overview
          12.1.2. Company Snapshot
          12.1.3. Company Market Share Analysis
          12.1.4. Company Product Portfolio
          12.1.5. Recent Developments
          12.1.6. SWOT Analysis
    12.2. Bayer AG
          12.2.1. Business Overview
          12.2.2. Company Snapshot
          12.2.3. Company Market Share Analysis
          12.2.4. Company Product Portfolio
          12.2.5. Recent Developments
          12.2.6. SWOT Analysis
    12.3. Beckman Coulter Inc.
          12.3.1. Business Overview
          12.3.2. Company Snapshot
          12.3.3. Company Market Share Analysis
          12.3.4. Company Product Portfolio
          12.3.5. Recent Developments
          12.3.6. SWOT Analysis
    12.4. bioMérieux SA
          12.4.1. Business Overview
          12.4.2. Company Snapshot
          12.4.3. Company Market Share Analysis
          12.4.4. Company Product Portfolio
          12.4.5. Recent Developments
          12.4.6. SWOT Analysis
    12.5. Bio-Rad Laboratories
          12.5.1. Business Overview
          12.5.2. Company Snapshot
          12.5.3. Company Market Share Analysis
          12.5.4. Company Product Portfolio
          12.5.5. Recent Developments
          12.5.6. SWOT Analysis
    12.6. Danaher Corporation
          12.6.1. Business Overview
          12.6.2. Company Snapshot
          12.6.3. Company Market Share Analysis
          12.6.4. Company Product Portfolio
          12.6.5. Recent Developments
          12.6.6. SWOT Analysis
    12.7. Exagen Inc.
          12.7.1. Business Overview
          12.7.2. Company Snapshot
          12.7.3. Company Market Share Analysis
          12.7.4. Company Product Portfolio
          12.7.5. Recent Developments
          12.7.6. SWOT Analysis
    12.8. F Hoffmann-La Roche Ltd.
          12.8.1. Business Overview
          12.8.2. Company Snapshot
          12.8.3. Company Market Share Analysis
          12.8.4. Company Product Portfolio
          12.8.5. Recent Developments
          12.8.6. SWOT Analysis
    12.9. Siemens Healthineers AG
          12.9.1. Business Overview
          12.9.2. Company Snapshot
          12.9.3. Company Market Share Analysis
          12.9.4. Company Product Portfolio
          12.9.5. Recent Developments
          12.9.6. SWOT Analysis
    12.10. Thermo Fisher Scientific
          12.10.1. Business Overview
          12.10.2. Company Snapshot
          12.10.3. Company Market Share Analysis
          12.10.4. Company Product Portfolio
          12.10.5. Recent Developments
          12.10.6. SWOT Analysis

List of Table

1. Global Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion) 

2. Global Equipment Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion) 

3. Global Consumables Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion) 

4. Global Others Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion) 

5. Global Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion) 

6. Global Spectrometry Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion) 

7. Global Electrophoresis Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion) 

8. Global Chromatography Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion) 

9. Global Proteomic Technology Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion) 

10. Global Immunoassays Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion) 

11. Global Others Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion) 

12. Global Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion) 

13. Global Antibiotics Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion) 

14. Global Antiarrhythmic Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion) 

15. Global Bronchodilators Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion) 

16. Global HIV/AIDS Drugs Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion) 

17. Global Antineoplastics Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion) 

18. Global Immunosuppressive Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion) 

19. Global Antiepileptic Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion) 

20. Global Others Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion) 

21. Global Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion) 

22. Global Hospitals Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion) 

23. Global Research and Academic Institutes Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion) 

24. Global Diagnostic Labs Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion) 

25. Global Others Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion) 

26. Global Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion) 

27. North America Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion) 

28. North America Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion) 

29. North America Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion) 

30. North America Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion) 

31. U.S. Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion) 

32. U.S. Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion) 

33. U.S. Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion) 

34. U.S. Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion) 

35. Canada Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion) 

36. Canada Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion) 

37. Canada Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion) 

38. Canada Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion) 

39. Mexico Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion) 

40. Mexico Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion) 

41. Mexico Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion) 

42. Mexico Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion) 

43. Europe Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion) 

44. Europe Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion) 

45. Europe Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion) 

46. Europe Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion) 

47. Germany Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion) 

48. Germany Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion) 

49. Germany Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion) 

50. Germany Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion) 

51. France Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion) 

52. France Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion) 

53. France Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion) 

54. France Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion) 

55. U.K. Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion) 

56. U.K. Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion) 

57. U.K. Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion) 

58. U.K. Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion) 

59. Italy Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion) 

60. Italy Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion) 

61. Italy Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion) 

62. Italy Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion) 

63. Spain Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion) 

64. Spain Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion) 

65. Spain Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion) 

66. Spain Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion) 

67. Asia Pacific Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion) 

68. Asia Pacific Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion) 

69. Asia Pacific Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion) 

70. Asia Pacific Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion) 

71. Japan Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion) 

72. Japan Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion) 

73. Japan Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion) 

74. Japan Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion) 

75. China Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion) 

76. China Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion) 

77. China Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion) 

78. China Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion) 

79. India Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion) 

80. India Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion) 

81. India Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion) 

82. India Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion) 

83. South America Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion) 

84. South America Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion) 

85. South America Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion)

86. South America Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion)

87. Brazil Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion) 

88. Brazil Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion) 

89. Brazil Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion) 

90. Brazil Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion)

91. Middle East and Africa Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion) 

92. Middle East and Africa Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion) 

93. Middle East and Africa Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion) 

94. Middle East and Africa Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion)

95. UAE Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion) 

96. UAE Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion) 

97. UAE Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion) 

98. UAE Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion)

99. South Africa Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion) 

100. South Africa Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion) 

101. South Africa Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion) 

102. South Africa Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion) 

List of Figures 

1. Global Therapeutic Drug Monitoring Market Segmentation

2. Therapeutic Drug Monitoring Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Therapeutic Drug Monitoring Market Attractiveness Analysis by Product Type

9. Global Therapeutic Drug Monitoring Market Attractiveness Analysis by Technology

10. Global Therapeutic Drug Monitoring Market Attractiveness Analysis by Drug Class

11. Global Therapeutic Drug Monitoring Market Attractiveness Analysis by End User

12. Global Therapeutic Drug Monitoring Market Attractiveness Analysis by Region

13. Global Therapeutic Drug Monitoring Market: Dynamics

14. Global Therapeutic Drug Monitoring Market Share by Product Type (2022 & 2032)

15. Global Therapeutic Drug Monitoring Market Share by Technology (2022 & 2032)

16. Global Therapeutic Drug Monitoring Market Share by Drug Class (2022 & 2032)

17. Global Therapeutic Drug Monitoring Market Share by End User (2022 & 2032)

18. Global Therapeutic Drug Monitoring Market Share by Regions (2022 & 2032)

19. Global Therapeutic Drug Monitoring Market Share by Company (2022)

This study forecasts revenue at global, regional, and country levels from 2019 to 2032. The Brainy Insights has segmented the global therapeutic drug monitoring market based on below mentioned segments:

Global Therapeutic Drug Monitoring Market by Product Type:

  • Equipment
  • Consumables
  • Others

Global Therapeutic Drug Monitoring Market by Technology:

  • Spectrometry
  • Electrophoresis
  • Chromatography
  • Proteomic Technology
  • Immunoassays
  • Others

Global Therapeutic Drug Monitoring Market by Drug Class:

  • Antibiotics
  • Antiarrhythmic
  • Bronchodilators
  • HIV/AIDS Drugs
  • Antineoplastics
  • Immunosuppressive
  • Antiepileptic
  • Others

Global Therapeutic Drug Monitoring Market by End User:

  • Hospitals
  • Research and Academic Institutes
  • Diagnostic Labs
  • Others

Global Therapeutic Drug Monitoring Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Ask for customization Request Sample Speak to analyst Inquire before buying

Flexible Purchase Options

  • Chapters of your choice
  • Quantitative Information for Historical & Forecasted Data
  • Regional/Country Level Reports
Request for Special Pricing

Get in touch with us

+1-315-215-1633

sales@thebrainyinsights.com

Why choose us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date